Question explored with the scientific record
Iodine tablets
Iodine is essential, but the dose window is narrow. The evidence here does not answer whether iodine tablets help or harm a healthy person.
The only clinical trial in the evidence tested oral iodine in very preterm infants at 30 µg/kg/day. It found the supplement did not prevent neonatal hypothyroxinemia or improve any neonatal outcome [1]. Iodine intake did correlate with thyroid hormone levels, but breast milk was the main source, not the tablet [1]. That is a null result in a vulnerable population where deficiency is a real risk.
The review evidence confirms that excess iodine can act as an endocrine disruptor. It impairs thyroid hormone synthesis through oxidative stress, interfering with the sodium-iodide symporter (NIS) and thyroid peroxidase (TPO) [2]. The Wolff-Chaikoff effect is the acute shutdown of hormone production when iodide is too high [2]. In people with autoimmune susceptibility, excess iodine can trigger or worsen Hashimoto’s thyroiditis [7]. The safe range is a U-shaped curve: harm from too little and harm from too much.
| Population | Finding | Source |
|---|---|---|
| Very preterm infants, 30 µg/kg/day oral iodine | No prevention of hypothyroxinemia, no improved outcomes | [1] |
| General population, excess iodine | Endocrine disruptor via ROS, impairs NIS/TPO, triggers Wolff-Chaikoff effect | [2] |
| Susceptible individuals, excess iodine | Can trigger or worsen Hashimoto’s thyroiditis | [7] |
The evidence retrieved does not contain a single study testing iodine tablets in a healthy adult or child for general wellness, thyroid support, or any specific clinical endpoint. The gap itself matters. There is no trial showing benefit, and there is mechanistic evidence of harm from excess.
My call: for a healthy person with adequate dietary iodine, there is no evidence that iodine tablets provide any benefit, and there is plausible mechanistic evidence that excess can disrupt thyroid function. Confidence: moderate. The evidence is thin and does not address the question directly.
Sources examined 7
-
Oral Iodine Supplementation in Very Low Birth Weigh Infants. Thyroid Function and Neurodevelopmental Follow Up at 24 Months. A Randomized Clinical Trial
Oral iodine supplementation at 30 μg/kg/day in very preterm infants did not prevent neonatal hypothyroxinemia or improve neonatal outcomes, though iodine intake correlated with thyroid hormone levels and breast milk emerged as the main iodine source.
DOI: 10.26420/annalsthyroidres.2021.1075 -
Iodine as a potential endocrine disruptor—a role of oxidative stress
A comprehensive review examining whether iodine acts as an endocrine disruptor via oxidative stress, summarizing evidence that excess iodine can impair thyroid hormone synthesis through ROS-related interference with NIS and TPO and discussing the balance between iodine deficienc…
DOI: 10.1007/s12020-022-03107-7 -
The effects of growth factors and serum on DNA synthesis and differentiation in thyroid cells in culture
Growth factors like EGF and serum raise DNA synthesis in cultured ovine thyroid cells but impair iodine uptake/organification; insulin boosts DNA synthesis without compromising differentiated function; TSH supports differentiation and can interact with growth factors to enhance …
DOI: 10.1016/0303-7207(84)90112-6 -
The Effect of Oral Administration of Iodine to Patients with Goiter and Hypothyroidism due to Defective Synthesis of Thyroglobulin
Three siblings with congenital goiter and hypothyroidism due to defective thyroglobulin synthesis were given 1 mg/day of iodide for 64 days; iodine increased serum T3 and T4 (and free T4) while thyroglobulin remained low, suggesting that excess iodine can enhance hormone product…
DOI: 10.1089/thy.1996.6.11 -
Two selective spectrophotometric methods for the determination of amoxicillin and cefadroxil
Two selective spectrophotometric methods using N-bromosuccinimide or N-chlorosuccinimide in alkaline medium enable simple, rapid determination of amoxicillin and cefadroxil in pharmaceutical dosage forms.
DOI: 10.1039/an9962100641 -
Determination of penicillin in pharmaceutical formulations by flow injection analysis using an optimised immobilised penicillinase reactor and iodometric detection
An automated flow-injection analysis method using an immobilised penicillinase reactor and iodometric detection is developed, optimized, and validated for rapid, reliable quantification of penicillin in a range of pharmaceutical formulations, with comparison to mercurimetric tit…
DOI: 10.1016/0731-7085(90)80006-b -
Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation
This is a comprehensive narrative review summarizing current understanding of Hashimoto's thyroiditis, including pathogenic mechanisms (genetic, epigenetic, and environmental factors), diagnostic protocols, therapeutic strategies, comorbidity with other autoimmune diseases, and …
DOI: 10.1016/j.autrev.2020.102649